Ad is loading...
NPCE
Price
$8.98
Change
-$0.70 (-7.23%)
Updated
Nov 15 closing price
108 days until earnings call
STVN
Price
$19.00
Change
-$1.50 (-7.32%)
Updated
Nov 15 closing price
108 days until earnings call
Ad is loading...

NPCE vs STVN

Header iconNPCE vs STVN Comparison
Open Charts NPCE vs STVNBanner chart's image
Neuropace
Price$8.98
Change-$0.70 (-7.23%)
Volume$115.82K
CapitalizationN/A
Stevanato Group SpA
Price$19.00
Change-$1.50 (-7.32%)
Volume$507.61K
CapitalizationN/A
NPCE vs STVN Comparison Chart
Loading...
NPCE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
STVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
NPCE vs. STVN commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPCE is a Sell and STVN is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (NPCE: $8.98 vs. STVN: $19.00)
Brand notoriety: NPCE and STVN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NPCE: 145% vs. STVN: 91%
Market capitalization -- NPCE: $385.2M vs. STVN: $8.76B
NPCE [@Medical Specialties] is valued at $385.2M. STVN’s [@Medical Specialties] market capitalization is $8.76B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NPCE’s FA Score shows that 0 FA rating(s) are green whileSTVN’s FA Score has 0 green FA rating(s).

  • NPCE’s FA Score: 0 green, 5 red.
  • STVN’s FA Score: 0 green, 5 red.
According to our system of comparison, NPCE is a better buy in the long-term than STVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NPCE’s TA Score shows that 5 TA indicator(s) are bullish while STVN’s TA Score has 3 bullish TA indicator(s).

  • NPCE’s TA Score: 5 bullish, 5 bearish.
  • STVN’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, NPCE is a better buy in the short-term than STVN.

Price Growth

NPCE (@Medical Specialties) experienced а +19.57% price change this week, while STVN (@Medical Specialties) price change was -12.76% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

NPCE is expected to report earnings on Mar 05, 2025.

STVN is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STVN($8.76B) has a higher market cap than NPCE($385M). NPCE YTD gains are higher at: -12.900 vs. STVN (-30.377). STVN has higher annual earnings (EBITDA): 272M vs. NPCE (-22.83M). STVN has more cash in the bank: 70.4M vs. NPCE (66.5M). NPCE has less debt than STVN: NPCE (72.4M) vs STVN (397M). STVN has higher revenues than NPCE: STVN (1.09B) vs NPCE (65.4M).
NPCESTVNNPCE / STVN
Capitalization385M8.76B4%
EBITDA-22.83M272M-8%
Gain YTD-12.900-30.37742%
P/E RatioN/A52.75-
Revenue65.4M1.09B6%
Total Cash66.5M70.4M94%
Total Debt72.4M397M18%
TECHNICAL ANALYSIS
Technical Analysis
NPCESTVN
RSI
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
76%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
NPCE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
STVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PSK34.48-0.01
-0.03%
SPDR® ICE Preferred Securities ETF
KHYB24.98-0.06
-0.23%
KraneShares Asia Pacific Hi Inc USD ETF
EWJ67.49-0.33
-0.49%
iShares MSCI Japan ETF
RSST23.52-0.57
-2.37%
Return Stacked® US Stocks & Mgd Futs ETF
KARS21.77-0.75
-3.33%
KraneShares Eltc Vhl and Ft Mbly ETF

NPCE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NPCE has been loosely correlated with FNA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if NPCE jumps, then FNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NPCE
1D Price
Change %
NPCE100%
-7.23%
FNA - NPCE
36%
Loosely correlated
+3.20%
STVN - NPCE
34%
Loosely correlated
-7.32%
SHC - NPCE
31%
Poorly correlated
-4.54%
IRMD - NPCE
28%
Poorly correlated
-3.56%
OM - NPCE
27%
Poorly correlated
-8.01%
More

STVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, STVN has been loosely correlated with WST. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if STVN jumps, then WST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STVN
1D Price
Change %
STVN100%
-7.32%
WST - STVN
35%
Loosely correlated
-6.99%
NPCE - STVN
34%
Loosely correlated
-7.23%
ICUI - STVN
29%
Poorly correlated
-2.38%
CUTR - STVN
26%
Poorly correlated
-2.11%
UFPT - STVN
25%
Poorly correlated
-4.69%
More